Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
MGNX's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: No Debt )
MGNX' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.69
MGNX's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 0.69 )
MGNX' s 10-Year Equity to Asset Range
Min: -0.26   Max: 0.73
Current: 0.69

-0.26
0.73
Interest Coverage No Debt
MGNX's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: No Debt )
MGNX' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

Z-Score: 5.19
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -19.32
MGNX's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -19.32 )
MGNX' s 10-Year Operating margin (%) Range
Min: 0.63   Max: 12.86
Current: -19.32

0.63
12.86
Net-margin (%) -20.26
MGNX's Net-margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -20.26 )
MGNX' s 10-Year Net-margin (%) Range
Min: -0.45   Max: 13.1
Current: -20.26

-0.45
13.1
ROE (%) -16.66
MGNX's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -16.66 )
MGNX' s 10-Year ROE (%) Range
Min: -0.74   Max: -0.74
Current: -16.66

ROA (%) -9.56
MGNX's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -9.56 )
MGNX' s 10-Year ROA (%) Range
Min: -0.29   Max: 14.36
Current: -9.56

-0.29
14.36
ROC (Joel Greenblatt) (%) -241.28
MGNX's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -241.28 )
MGNX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.82   Max: 502.14
Current: -241.28

8.82
502.14
» MGNX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

MGNX Guru Trades in

Q4 2013

MGNX Guru Trades in Q4 2013

John Griffin 900,000 sh (New)
» More
Q1 2014

MGNX Guru Trades in Q1 2014

Steven Cohen 870,189 sh (New)
John Griffin 900,000 sh (unchged)
» More
Q2 2014

MGNX Guru Trades in Q2 2014

Jean-Marie Eveillard 334,285 sh (New)
George Soros 19,488 sh (New)
Steven Cohen 2,017,066 sh (unchged)
John Griffin 900,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with MGNX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Jean-Marie Eveillard 2014-06-30 New Buy0.02%$18.26 - $29.47 $ 20.2-4%334285
George Soros 2014-06-30 New Buy$18.26 - $29.47 $ 20.2-4%19488
John Griffin 2013-12-31 New Buy0.25%$21.82 - $28.48 $ 20.2-23%900000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Macrogenics Inc

Weekly 3-Year Low Highlights: KN, MGNX, MIXT, EDMC
According to GuruFocus list of three-year lows, Knowles Corporation, Macrogenics Inc., MiX Telematics Ltd. and Education Management Corp have all reached their three-year lows. Read more...

Ratios

vs
industry
vs
history
P/B 4.00
MGNX's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 4.00 )
MGNX' s 10-Year P/B Range
Min: 3.33   Max: 12.85
Current: 4

3.33
12.85
P/S 6.80
MGNX's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 6.80 )
MGNX' s 10-Year P/S Range
Min: 1.12   Max: 5.65
Current: 6.8

1.12
5.65
EV-to-EBIT -32.95
MGNX's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -32.95 )
MGNX' s 10-Year EV-to-EBIT Range
Min: 152.8   Max: 1227.8
Current: -32.95

152.8
1227.8
Current Ratio 6.65
MGNX's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 6.65 )
MGNX' s 10-Year Current Ratio Range
Min: 1.35   Max: 6.89
Current: 6.65

1.35
6.89
Quick Ratio 6.65
MGNX's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 6.65 )
MGNX' s 10-Year Quick Ratio Range
Min: 1.35   Max: 6.89
Current: 6.65

1.35
6.89

Valuation & Return

vs
industry
vs
history
Price/Net Cash 4.40
MGNX's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 4.40 )
MGNX' s 10-Year Price/Net Cash Range
Min: 4.73   Max: 9.94
Current: 4.4

4.73
9.94
Price/Net Current Asset Value 4.34
MGNX's Price/Net Current Asset Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 4.34 )
MGNX' s 10-Year Price/Net Current Asset Value Range
Min: 4.66   Max: 9.73
Current: 4.34

4.66
9.73
Price/Tangible Book 4.04
MGNX's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 4.04 )
MGNX' s 10-Year Price/Tangible Book Range
Min: 4.34   Max: 8.76
Current: 4.04

4.34
8.76
Price/Median PS Value 2.80
MGNX's Price/Median PS Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 2.80 )
MGNX' s 10-Year Price/Median PS Value Range
Min: 0.66   Max: 3.01
Current: 2.8

0.66
3.01
Earnings Yield (Greenblatt) 0.10
MGNX's Earnings Yield (Greenblatt) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 0.10 )
MGNX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.7
Current: 0.1

0.1
0.7

Business Description

Industry: »
Compare: » details
Traded in other countries:M55.Germany
» More Articles for MGNX

Headlines

Articles On GuruFocus.com
Weekly 3-Year Low Highlights: KN, MGNX, MIXT, EDMC May 27 2014 

More From Other Websites
Nasdaq stocks posting largest percentage decreases Sep 22 2014
Biotech Analyst Optimism: Price Targets Post-IPO Aug 29 2014
Stock Futures In Positive Mood; Bon Ton Stores Skid Lower Aug 21 2014
MACROGENICS INC Financials Aug 12 2014
MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference Aug 06 2014
MACROGENICS INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 05 2014
MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results Aug 05 2014
MACROGENICS INC Files SEC form 10-Q, Quarterly Report Aug 05 2014
Q2 2014 MacroGenics Inc Earnings Release - After Market Close Aug 05 2014
MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call Jul 29 2014
MACROGENICS INC Files SEC form 8-K, Other Events Jul 25 2014
MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients Jul 24 2014
Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A) Jul 22 2014
Coverage initiated on MacroGenics by Oppenheimer Jul 11 2014
CMC Biologics and MacroGenics Enter into Process Validation and Clinical Manufacturing Agreement for... Jun 17 2014
MacroGenics: A Balanced Small Cap Bio With A Great Entry Level Opportunity Jun 11 2014
MACROGENICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 11 2014
MacroGenics (MGNX) Worth Watching: Stock Up 5.1% May 30 2014
MACROGENICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... May 29 2014
3 Stocks Rising on Unusual Volume May 29 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK